Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074693 · ClinicalTrials.gov registry record · NA
Mobile Health and COVID-19
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 822
- Enrollment target
NCT05074693 is a NA study that has completed, run by University of Houston. The registered enrollment target is 822 participants.
The verdict
NCT05074693, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 822 participants
- Enrollment target
Study Summary
The proposed research focuses on evaluating the mobile application, Easing Anxiety Sensitivity for Everyone (EASE), to improve overall public health that concerns risks and mental health status during the coronavirus disease of 2019 (COVID-19) pandemic and to minimize the existing health disparities among Black, Hispanic and Latino, and American Indian (BLAI) individuals during this time. EASE provides COVID-19 symptom monitoring, exposure management skills, and psychoeducation on stress and it's impact on infection and disease susceptibility. This study aims to compare the effect of EASE to an empirical measurement of standard-of-care digital intervention and to identify the effective mechanisms in EASE.
Interventions
- OTHER EASE app
- OTHER INSIGHT (Control) App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 822 participants |
| Start Date | 2021-12-20 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05074693
The ClinicalTrials.gov registry entry for NCT05074693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 822 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EASE app is the first listed.
NCT05074693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05074693 about?
NCT05074693 is a clinical study titled "Mobile Health and COVID-19". The proposed research focuses on evaluating the mobile application, Easing Anxiety Sensitivity for Everyone (EASE), to improve overall public health that concerns risks and mental health status during the coronavirus disease of 2019 (COVID-19) pandemic and to minimize the existing health disparities...
What is the current status of trial NCT05074693?
This trial is currently completed. It is a NA study. The enrollment target is 822 participants. The study started on 2021-12-20. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT05074693?
The interventions under investigation include: EASE app (OTHER), INSIGHT (Control) App (OTHER).
Who is sponsoring clinical trial NCT05074693?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.